David J. Mazzo - Jan 9, 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role
Chief Executive Officer, Director
Signature
James Nisco, Attorney-in-Fact for David J. Mazzo
Stock symbol
LSTA
Transactions as of
Jan 9, 2023
Transactions value $
-$34,622
Form type
4
Date filed
1/11/2023, 03:07 PM
Previous filing
Sep 2, 2022
Next filing
Jan 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $0 +60K +121.74% $0.00 109K Jan 9, 2023 Direct F1, F2
transaction LSTA Common Stock Tax liability -$23.5K -7.85K -7.18% $3.00 101K Jan 9, 2023 Direct F2, F3
transaction LSTA Common Stock Tax liability -$11.1K -3.47K -3.42% $3.20 98K Jan 10, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LSTA Stock Options (Right to Buy) Award $0 +30K $0.00 30K Jan 9, 2023 Common Stock 30K $3.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 60,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2 Includes 69,783 unvested restricted stock.
F3 Shares withheld as payment of a tax liability on vesting of restricted stock.
F4 Includes 63,100 unvested restricted stock.
F5 One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.